SCHEMBL24637652

SCHEMBL24637652

CC(C)(C)Cc1ccc(C(c2ccccc2)(c2ccccc2)N2CCN(C(=O)Oc3ccccc3)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
RAB9A P51151 3/20 0.45
NPC1 O15118 2/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KMT2A Q03164 1/20 0.44
MGLL Q99685 2/20 0.44
NPY2R P49146 3/20 0.43
CYP2D6 P10635 2/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.42
SMO Q99835 1/20 0.42
CHRM1 P11229 3/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523154 0.86 MGLL (0.56) GAARAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL2867370 0.74 GPR119 (0.53) MAPTSMN1; SMN2KMT2AUSP2ALDH1A1
SCHEMBL27906266 0.74 TSHR (0.57) GAARAB9ANPC1MAPTSMN1; SMN2
SCHEMBL11882343 0.73 MGLL (0.72) GAARAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL952359 0.71 GAA (0.60) GAARAB9ANPC1MAPTHTT
SCHEMBL13152706 0.71 GAA (0.68) GAARAB9ANPC1MGLLNPY2R
SCHEMBL24856088 0.70 GAA (0.46) GAARAB9ANPC1MAPTHTT
SCHEMBL10666406 0.70 GAA (0.63) GAARAB9ANPC1MAPTSMN1; SMN2
SCHEMBL20324400 0.70 LMNA (0.42) GAARAB9ANPC1MAPTSMN1; SMN2
SCHEMBL8747418 0.69 RAB9A (0.69) GAARAB9ANPC1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3554554-B1 EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS INC (US) 2022-09-07 EP disclosed